The changing face of paediatric HIV: A review of the evolving clinical characteristics of a paediatric and adolescent patients at a clinic in Johannesburg, South Africa.

International Workshop on HIV Pediatrics 2020

Cognitive outcomes at 7 and 9 years after the Children with HIV Early Antiretroviral (CHER) trial

International Workshop on HIV Pediatrics 2020

Low access to viral load monitoring and poor virological outcomes in children and adolescents living with HIV in West Africa

International Workshop on HIV Pediatrics 2020

Time to repeat viral load testing following an unsuppressed viral load among adolescents and young adults in Kenya

International Workshop on HIV Pediatrics 2020

Fidelity to a lay cadre-administered HIV risk screening tool used among orphans and vulnerable children in community settings in Tanzania

International Workshop on HIV Pediatrics 2020

Clinical outcomes of infants identified HIV-positive at birth through routine point-of-care early infant HIV diagnosis; a pilot program in Eswatini

International Workshop on HIV Pediatrics 2020

Reaching the 1st 95: Maximizing index testing coverage in children of women living with HIV

International Workshop on HIV Pediatrics 2020

Expand HIV Testing in Youth at an Urban Children’s Hospital – Sustainable or Not?

International Workshop on HIV Pediatrics 2020

PK and safety of F/TAF with boosted 3rd agents in children with HIV

International Workshop on HIV Pediatrics 2020

Plasma Exposure-Viral Load Response Analysis for Dolutegravir in Children with HIV-1: Results from IMPAACT P1093

International Workshop on HIV Pediatrics 2020

Weight trajectory in children and adolescents who switched to TAF-based regimens

International Workshop on HIV Pediatrics 2020

Acceptability & palatability of low dose B/F/TAF & E/C/F/TAF in children (≥2y) with HIV

International Workshop on HIV Pediatrics 2020

HIV-infected treatment-experienced children and adolescents from Sub-Saharan Africa: clinical outcomes on third-line antiretroviral treatment in the New Horizons drug donation program

International Workshop on HIV Pediatrics 2020

Optimized ART regimen transition: Experiences at ICAP supported facilities in Manzini, Eswatini.

International Workshop on HIV Pediatrics 2020

Antiretroviral Drug Optimization and Viral Suppression Amongst Children and Adolescents Living with HIV in four States in Nigeria

International Workshop on HIV Pediatrics 2020

Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action

International Workshop on HIV Pediatrics 2020

Associations of Nevirapine-based ART regimens with neuropsychological outcomes in HIV-positive children

International Workshop on HIV Pediatrics 2020

Retention and viral suppression among child -caregiver pairs enrolled in family centered differentiated model of care in Kenya, 2019

International Workshop on HIV Pediatrics 2020

Virological failure is consistent with acquired HIV drug resistance among vertically-infected adolescents: evidence from the EDCTP-READY study.

International Workshop on HIV Pediatrics 2020

Significant life events and viral suppression outcomes in children starting antiretroviral therapy in South Africa

International Workshop on HIV Pediatrics 2020

Children newly diagnosed with HIV in the UK and Ireland between 2000 and 2018: a population- level overview

International Workshop on HIV Pediatrics 2020

Trends in the prevalence of overweight and obesity among children and adolescents living with perinatally-acquired HIV in the UK and Ireland.

International Workshop on HIV Pediatrics 2020

Cascade of care in children and adolescents with HIV in Russian Federation

International Workshop on HIV Pediatrics 2020

“HIV is the easy part”: A qualitative study on perceived biopsychosocial needs among U.S. parents who have internationally adopted children living with HIV

International Workshop on HIV Pediatrics 2020